FLEX:NASDAQFlex Ltd. Analysis
Data as of 2026-03-10 - not real-time
$60.91
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Flex Ltd. is trading at $60.91, just above the calculated support level of $58.53 and below its 20‑day SMA of $63.76, indicating a near‑term price floor but limited upside in the immediate term. The 20‑day SMA sits marginally above the 50‑day SMA, offering a modest bullish bias, while the RSI at 44 suggests the stock is not yet oversold. However, the MACD histogram remains negative and the MACD signal is flagged as bearish, pointing to potential downside momentum. Volume trends are decreasing, and the 30‑day volatility is high at roughly 56%, compounded by a beta of 1.68, which amplifies market swings. On the fundamentals side, revenue grew 8% YoY to $7.1 B, beating guidance, and operating margins improved to 6.5% (up 40 bps), but EPS missed consensus expectations, creating mixed earnings sentiment. The DCF fair value of $43.5 is well below the current price, implying the market is pricing in significant growth expectations. Forward PE of 16.7 versus an industry PE of 36.9 suggests relative valuation advantage, while the forward‑PE gap reinforces a growth narrative. The company carries a high debt‑to‑equity ratio near 98% and a leverage‑heavy balance sheet, which could constrain cash flow flexibility. Overall, the stock presents a blend of growth upside and valuation risk, with technical indicators warning of short‑term weakness.
Investors should weigh the strong revenue momentum and improving margins against the elevated leverage, high volatility, and overvaluation relative to DCF. Target prices from analysts average $75, offering a potential 24% upside, but the downside risk remains given the bearish technical signals and debt profile.
Investors should weigh the strong revenue momentum and improving margins against the elevated leverage, high volatility, and overvaluation relative to DCF. Target prices from analysts average $75, offering a potential 24% upside, but the downside risk remains given the bearish technical signals and debt profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish MACD
- Decreasing volume and high short‑term volatility
- Mixed earnings signal (EPS miss vs revenue beat)
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth of 8% and expanding operating margins
- Forward PE of 16.7 versus industry average of 36.9
- Analyst target median price of $75 indicating upside potential
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio (~98%) limiting financial flexibility
- DCF fair value well below market price, suggesting overvaluation
- Sustained cash flow generation but modest free cash flow conversion
Key Metrics & Analysis
Financial Health
Revenue Growth7.70%
Profit Margin3.17%
P/E Ratio27.3
ROE16.85%
ROA4.53%
Debt/Equity97.99
P/B Ratio4.4
Op. Cash Flow$1.7B
Free Cash Flow$934.5M
Industry P/E36.8
Technical Analysis
TrendBullish
RSI43.8
Support$58.53
Resistance$67.71
MA 20$63.76
MA 50$63.57
MA 200$57.21
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$43.50
Target Price$76.13
Upside/Downside24.98%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.68
Volatility55.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.